


Dr. Sarah Hoffe, MD
book an appointment

Dr. Sarah Hoffe, MD
Radiation Oncology
Dr. Sarah Hoffe, MD is a radiation oncologist in Tampa, FL and has over 30 years of experience in the medical field. She graduated from University of Vermont Larner College of Medicine in 1993. She is affiliated with Moffitt Cancer Center Magnolia Campus. She is accepting new patients and telehealth appointments.
Locations
Moffitt Cancer Center, Magnolia Campus
At a Glance
- Area of Expertise • Dr. Hoffe specializes in the area of Radiation Oncology. See board certifications
- Explains Conditions Well • Patients said this doctor explains conditions well. See reviews
- Offers Telehealth • This doctor offers telehealth appointments. Call the office to schedule an appointment.
- Trustworthy • Patients said this doctor is trustworthy. See reviews
More Radiation Oncology Specialists at Moffitt Cancer Center
Experience Check
Search for experience in a specific area
Dr. Hoffe's Reviews
Likelihood to recommend Dr. Hoffe
5 star | 100% | 100% |
4 star | 0% | 0% |
3 star | 0% | 0% |
2 star | 0% | 0% |
1 star | 0% | 0% |
Your trust is our top concern.
We strive to keep reviews honest, trustworthy, and fair.Doctors can not pay for good reviews, nor can they pay to have negative reviews removed.
We monitor all reviews to ensure they comply with our guidelines and don’t include personal information, profanity, libel, defamation, harassment, obscenity or fraud.
Any reviews that are deemed fraudulent or violate our guidelines will be removed immediately.
All reviews are confirmed and audited before publication, and community members have the ability to flag inappropriate content for further review by our team.
- Trusted the provider's decisions
- Trusted the provider's decisions
- Trusted the provider's decisions
- Trusted the provider's decisions
- Trusted the provider's decisions
- Trusted the provider's decisions
- Trusted the provider's decisions
- Trusted the provider's decisions
- Trusted the provider's decisions
- Trusted the provider's decisions
- Trusted the provider's decisions
- Trusted the provider's decisions
- Trusted the provider's decisions
Leave a review
How was your experience with Dr. Hoffe?Is this your profile?
Respond to reviews, add information, and reach more patients. Claiming is free and only takes a minute.
Claim your profileOverall Patient Satisfaction
Likelihood of recommending Dr. Hoffe to family and friends is 5 out of 5
Insurance Check
Search for your insurance carrier and choose your plan type
About Me
Watch Dr. Hoffe's Video
care philosophy
Dr Sarah Hoffe is the Section Head of GI Radiation Oncology at Moffitt Cancer Center and joined the faculty in 2006. She is a Senior Member at Moffitt and Professor in the University Of South Florida Morsani College Of Medicine's Department of...read morebiography
Dr. Sarah Hoffe is the Section Head of GI Radiation Oncology at Moffitt Cancer Center and joined the faculty in 2006. She is a Senior Member at Moffitt and Professor in tRadiation Oncology
*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Duke University Medical Center|memorial Sloan Kettering Cancer Center
Residency HospitalUniversity Of Vermont Larner College Of Medicine
Medical School, 1993
Healthgrades receives board action history for physicians and physician assistants. The information displayed here is sourced from independent information providers, such as state board websites, and may not be the most up-to-date information. Healthgrades makes no representations with respect to the accuracy of any information provided here and assumes no responsibility or liability for such information.
Learn more about medical license public record checkEvaluation of Tumor DNA Sequencing Results in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma Stratified byTP53Mutation Status, 2022-02-26
Novel MR-Guided Radiotherapy Elective Rotation for Radiation Oncology Trainees, 2020-09-29
The Effect of Histologic Grade on Neoadjuvant Treatment Outcomes in Esophageal Cancer, 2022-05-16